(19)
(11) EP 4 824 077 A1

(12)

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 24905015.4

(22) Date of filing: 13.12.2024
(51) International Patent Classification (IPC): 
C07K 1/107(2006.01)
A61K 47/62(2017.01)
A61K 47/65(2017.01)
A61K 47/54(2017.01)
A61K 47/64(2017.01)
C07K 1/113(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 47/64; C12P 21/00; A61P 35/00; C12Y 114/18001; C12N 9/0071; C07K 2319/50; C12N 9/0069; C07K 2319/61; C07D 491/22; C07H 15/252
(86) International application number:
PCT/US2024/060174
(87) International publication number:
WO 2025/129098 (19.06.2025 Gazette 2025/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 14.12.2023 US 202363610252 P

(71) Applicant: Catena Biosciences, Inc.
Berkeley, CA 94720 (US)

(72) Inventors:
  • LAU, Andrew
    Berkeley, California 94720 (US)
  • LOBBA, Marco
    Berkeley, California 94720 (US)
  • KENDALL, Richard
    Berkeley, California 94720 (US)
  • JOHRI, Saurabh
    Berkeley, California 94720 (US)
  • NGUYEN, Maxwell
    Berkeley, California 94720 (US)
  • TRINTER, Devin
    Berkeley, California 94720 (US)

(74) Representative: Elkington and Fife LLP 
Prospect House 8 Pembroke Road
Sevenoaks, Kent TN13 1XR
Sevenoaks, Kent TN13 1XR (GB)

   


(54) TYROSINASE-BASED CONJUGATE COMPOSITIONS AND METHODS OF USE